Resource-sparing and cost-effective strategies in current management of breast cancer.
Breast cancer is the leading cause of death in women throughout the world. There have been significant advances in the practice of breast oncology over the past few years. However, most of these advances have an associated price tag or are resource intensive. The present article discusses means to achieve cost-effectiveness in the treatment of breast cancer, while retaining the benefits of the modern anticancer approaches.
Munshi
Anusheel
A
Department of Radiation Oncology, Tata Memorial Hospital, Parel, Mumbai, India. anusheel8@hotmail.com
D000970:Antineoplastic Agents / Q000191:economics / Q000627:therapeutic use; D001859:Bone Neoplasms / Q000532:radiotherapy / Q000556:secondary; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000532:radiotherapy*; D003131:Combined Modality Therapy; D003362:Cost-Benefit Analysis; D005260:Female; D006801:Humans; D040841:Resource Allocation
D000970:Antineoplastic Agents